SS Innovations International, Inc.
HealthcareNASDAQ:SSII · NASDAQ Capital Market
-$0.17 today
Vol 0.04M · Avg 0.06M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-31.7%
avg -117.1%
ROIC
-16.9%
avg -96.4%
ROA
-16.3%
avg -409.9%
Analysis
ROA is currently the strongest return metric at -16.3% versus its period average of -409.9%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Sudhir Srivastava | Founder, Chief Executive Officer & Chairman | $899,538.00 | — | 78 | $3.00M | 1.50% |
Vishwajyoti Srivastava | Chief Executive Officer of APAC & Director | $321,001.00 | — | 48 | $3.00M | 1.50% |
Barry F. Cohen | Chief Operating Officer of Americas & Director | $180,000.00 | — | 86 | $7.76M | 3.87% |
Amitesh Nigam | Head of Human Resources | — | — | — | — | — |
Rahul Kumar | Head of IP | — | — | — | $0.00 | <0.01% |
Rama Krishna Reddy | Chief Technology Officer of South Asia | — | — | — | — | — |
Milan Rao | Global Chief Operating Officer & Chief Financial Officer | — | — | 55 | $120,000.00 | 0.06% |
Vilayat Ali | Head of Marketing & Digital Media | — | — | — | — | — |
Avinash Kumar | Chief Operating Officer of India | — | — | — | $0.00 | <0.01% |
Amit Garg | Manager of Finance & Accounts | — | — | — | — | — |
Colin Eke | Senior Vice President of Global Business Development | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
3
$5.20M
Sells
0
$0.00
Net Sentiment
+$5.20M
Net buying
Most Active
MOLL FREDERIC H
1 transactions
Analysis
Insiders reported 3 buys worth $5.20M and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $5.20M. MOLL FREDERIC H was the most active insider with 1 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | N/A | N/A1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Analysis will appear once historical growth or forward estimates are available for this company.
Competitors
Peer companies in the same sector
Establishment Labs Holdings Inc.
NASDAQ:ESTA
$2.42B
Progyny, Inc.
NASDAQ:PGNY
$2.09B
UFP Technologies, Inc.
NASDAQ:UFPT
$1.82B
Omnicell, Inc.
NASDAQ:OMCL
$1.72B
PROCEPT BioRobotics Corporation
NASDAQ:PRCT
$1.46B
AdaptHealth Corp.
NASDAQ:AHCO
$1.38B
Teladoc Health, Inc.
NYSE:TDOC
$1.32B
Schrödinger, Inc.
NASDAQ:SDGR
$1.08B
CONMED Corporation
NYSE:CNMD
$1.05B
Omada Health
NASDAQ:OMDA
$1.02B
Who manages SSII?
SS Innovations International, Inc. (SSII) lists 11 active executives. The top listed executive is Amitesh Nigam, Head of Human Resources.
Are SSII insiders buying or selling?
Recent insider activity shows net buying of $38.47M.
Explore More
Continue the stock analysis
Jump to another research area for this company.